SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Rh (RH) trades at a trailing P/E of 17.6, forward P/E of 18.9. Trailing earnings yield is 5.69%, forward earnings yield 5.29%. PEG 0.24 (Peter Lynch undervalued ≤1.0). Graham Number is $21.96.
Criteria proven by this page:
- VALUE (90/100, Pass) — P/E is below market average (17.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.24); analyst target implies upside (+59.1%); earnings yield beats bond yields (5.69%).
- PEG Ratio 0.24 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.69% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $208.00 (+59.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 58/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RH
Valuation Multiples
P/E (TTM)17.6
Forward P/E18.9
PEG Ratio0.24
Forward PEG1.97
P/B Ratio36.16
P/S Ratio0.64
EV/EBITDA12.2
Per Share Data
EPS (TTM)$6.64
Forward EPS (Est.)$6.91
Book Value / Share$3.23
Revenue / Share$183.07
FCF / Share$13.29
Yields & Fair Value
Earnings Yield5.69%
Forward Earnings Yield5.29%
Dividend Yield0.00%
Graham Number$21.96
SharesGrow IV$281.24 (+115.1%)
Analyst Target$208.00 (+59.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
203.6 |
-2.16 |
1.20 |
0.52 |
- |
| 2018 |
1,166.4 |
-30.33 |
-346.62 |
1.04 |
- |
| 2019 |
23.9 |
0.00 |
-93.10 |
1.44 |
- |
| 2020 |
18.1 |
0.17 |
213.58 |
1.50 |
- |
| 2021 |
35.0 |
1.78 |
21.30 |
3.34 |
- |
| 2022 |
12.4 |
0.09 |
7.32 |
2.28 |
- |
| 2023 |
13.9 |
-0.45 |
9.35 |
2.04 |
- |
| 2024 |
39.5 |
-0.55 |
-16.94 |
1.66 |
- |
| 2025 |
107.0 |
-2.75 |
-47.36 |
2.44 |
- |
| 2026 |
29.9 |
0.43 |
61.53 |
1.08 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$9.96 |
$2.85B |
$271.82M |
9.5% |
| 2021 |
$22.13 |
$3.76B |
$688.55M |
18.3% |
| 2021 |
$22.13 |
$3.76B |
$688.55M |
18.3% |
| 2022 |
$19.90 |
$3.59B |
$528.64M |
14.7% |
| 2022 |
$19.90 |
$3.59B |
$528.64M |
14.7% |
| 2023 |
$5.91 |
$3.03B |
$127.56M |
4.2% |
| 2023 |
$5.91 |
$3.03B |
$127.56M |
4.2% |
| 2024 |
$3.62 |
$3.18B |
$72.41M |
2.3% |
| 2024 |
$3.62 |
$3.18B |
$72.41M |
2.3% |
| 2025 |
$6.31 |
$3.44B |
$124.79M |
3.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$6.95 |
$6.64 – $7.25 |
$3.47B |
$3.38B – $3.54B |
11 |
| 2027 |
$9.87 |
$5.02 – $12.70 |
$3.77B |
$3.67B – $3.85B |
12 |
| 2028 |
$13.11 |
$7.85 – $18.88 |
$4.09B |
$4.05B – $4.16B |
11 |
| 2029 |
$18.96 |
$11.18 – $26.73 |
$4.56B |
$4.42B – $4.7B |
2 |
